BSE Live
Sep 05, 16:01Prev. Close
248.20
Open Price
257.85
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
Profit & Loss account of Trident Texofab (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 95.51 | 91.29 | 88.65 | 75.95 | 65.98 | |
Less: Excise/Sevice Tax/Other Levies | 4.55 | 4.39 | 3.19 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 90.96 | 86.90 | 85.46 | 75.95 | 65.98 | |
Total Operating Revenues | 90.96 | 86.90 | 85.46 | 75.95 | 65.98 | |
Other Income | 0.42 | 0.32 | 0.48 | 0.24 | 0.05 | |
Total Revenue | 91.39 | 87.22 | 85.94 | 76.19 | 66.03 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 8.44 | 0.00 | 0.00 | 0.00 | 62.82 | |
Purchase Of Stock-In Trade | 76.43 | 78.37 | 84.36 | 65.30 | 0.00 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.53 | 0.47 | 0.00 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | -6.09 | 1.14 | -2.76 | 7.08 | 0.00 | |
Employee Benefit Expenses | 2.46 | 1.92 | 0.67 | 0.66 | 0.90 | |
Finance Costs | 2.71 | 0.86 | 0.77 | 0.68 | 0.60 | |
Depreciation And Amortisation Expenses | 1.01 | 0.30 | 0.13 | 0.13 | 0.14 | |
Other Expenses | 4.90 | 3.08 | 1.21 | 1.29 | 1.28 | |
Total Expenses | 89.86 | 85.67 | 84.90 | 75.61 | 65.73 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1.53 | 1.55 | 1.04 | 0.58 | 0.30 | |
Exceptional Items | 0.00 | 0.14 | 0.00 | 0.00 | -0.21 | |
Profit/Loss Before Tax | 1.53 | 1.69 | 1.04 | 0.58 | 0.09 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 0.28 | 0.41 | 0.28 | 0.23 | 0.08 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 0.35 | -0.01 | 0.01 | 0.01 | -0.05 | |
Tax For Earlier Years | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 0.63 | 0.42 | 0.29 | 0.23 | 0.03 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 0.90 | 1.27 | 0.75 | 0.34 | 0.06 | |
Profit/Loss From Continuing Operations | 0.90 | 1.27 | 0.75 | 0.33 | 0.06 | |
Profit/Loss For The Period | 0.90 | 1.27 | 0.75 | 0.33 | 0.06 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 0.94 | 3.19 | 1.88 | 9.92 | 0.18 | |
Diluted EPS (Rs.) | 0.94 | 3.19 | 2.32 | 9.92 | 0.18 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 8.44 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.41 | 0.40 | 0.32 | 0.00 | 0.00 | |
Tax On Dividend | 0.08 | 0.08 | 0.07 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 0.00 | 10.00 | 10.00 | 0.00 | 0.00 |
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
05.04.2017
30.03.2017
29.03.2017
28.03.2017